La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Talos Energy a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Talos Energy..

Talos Energy (NYSE:TALO) Azioni, Catena delle Opzioni

TALOS ENERGY INC

Talos Energy

Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

DMLP

TALO

Gli analisti identificano tre società, attive in un settore chiave, che mostrano segnali di resilienza e potenziale di crescita.

Portafoglio in crisi? 3 azioni che possono essere un&#39;ancora di salvezza

Talos Energy Inc

Talon Energy Ltd

TALON INTERNATIONAL INC by Talon International, Inc.

Talon International Inc

Talon Metals Corp

<p>Stifel  analyst Parker Lane   maintains SPS Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPSC#NASDAQ">SPSC</a>) with a Buy and lowers the price target from $175 to $165.</p>


Price Target

Analyst Ratings

SPSC

Stifel Maintains Buy on SPS Commerce, Lowers Price Target to $165

<p>Wells Fargo  analyst Ken Gawrelski   maintains eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) with a Equal-Weight and raises the price target from $66 to $84.</p>


EBAY

Wells Fargo Maintains Equal-Weight on eBay, Raises Price Target to $84

<p>Stifel  analyst Parker Lane   maintains Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) with a Buy and raises the price target from $105 to $110.</p>


QTWO

Stifel Maintains Buy on Q2 Holdings, Raises Price Target to $110

<p>Wells Fargo  analyst Ken Gawrelski   maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Overweight and raises the price target from $783 to $811.</p>


Wells Fargo Maintains Overweight on Meta Platforms, Raises Price Target to $811

<p>Stifel  analyst Rick Wise   maintains Pulmonx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNG#NASDAQ">LUNG</a>) with a Buy and lowers the price target from $16 to $5.</p>


LUNG

Stifel Maintains Buy on Pulmonx, Lowers Price Target to $5

<p>Stifel  analyst Adam Borg   maintains PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) with a Buy and raises the price target from $200 to $220.</p>


Stifel Maintains Buy on PTC, Raises Price Target to $220

Rumors

IPOs

Figma IPO Price Indicating $95-$100/Share; IPO Priced At $33/Share On 36,937,080 Shares

<p>Stifel  analyst Steven Wieczynski   maintains OneSpaWorld Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSW#NASDAQ">OSW</a>) with a Buy and raises the price target from $23 to $25.</p>


Stifel Maintains Buy on OneSpaWorld Hldgs, Raises Price Target to $25

<p><a href="https://www.microsoft.com/en-us/security/blog/2025/07/31/frozen-in-transit-secret-blizzards-aitm-campaign-against-diplomats/" title="https://www.microsoft.com/en-us/security/blog/2025/07/31/frozen-in-transit-secret-blizzards-aitm-campaign-against-diplomats/">https://www.microsoft.com/en-us/security/blog/2025/07/31/frozen-in-transit-secret-blizzards-aitm-campaign-against-diplomats/</a></p>


MSFT

Microsoft Threat Intelligence Posts On X "Microsoft Threat Intelligence has uncovered a cyberespionage campaign by the Russian state actor we track as Secret Blizzard targeting embassies in Moscow using an adversary-in-the-middle (AiTM) position to deploy their custom ApolloShadow malware."

<p>Wells Fargo  analyst Ken Gawrelski   maintains Etsy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) with a Underweight and raises the price target from $41 to $57.</p>


ETSY

Wells Fargo Maintains Underweight on Etsy, Raises Price Target to $57

<p>Stifel  analyst J. Bruce Chan   maintains Old Dominion Freight Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) with a Buy and lowers the price target from $183 to $168.</p>


ODFL

Stifel Maintains Buy on Old Dominion Freight Line, Lowers Price Target to $168

<p>RBC Capital  analyst Ben Hendrix   maintains Chemed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHE#NYSE">CHE</a>) with a Outperform and lowers the price target from $640 to $589.</p>


RBC Capital Maintains Outperform on Chemed, Lowers Price Target to $589

<p>Stifel  analyst Paul Matteis   maintains Neurocrine Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) with a Buy and raises the price target from $166 to $174.</p>


NBIX

Stifel Maintains Buy on Neurocrine Biosciences, Raises Price Target to $174

<p>TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) will release its quarterly earnings report on Friday, 2025-08-01. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate TransAlta to report an <strong>earnings per share</strong> (EPS) of $0.07.</p>
<p>Investors in TransAlta are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<p>Here's a look at TransAlta's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td></td>
<td></td>
<td>0.14</td>
<td>0.07</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.07</td>
<td>-0.16</td>
<td>-0.09</td>
<td>0.13</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>-3.0%</td>
<td>-6.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<h3>Performance of TransAlta Shares</h3>
<p>Shares of TransAlta were trading at $12.27 as of July 30. Over the last 52-week period, shares are up 51.0%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/TAC/earnings"><strong>To track all earnings releases for TransAlta visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

A Glimpse of TransAlta's Earnings Potential

<p>Stifel  analyst Brad Reback   maintains Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) with a Buy and raises the price target from $550 to $650.</p>


Stifel Maintains Buy on Microsoft, Raises Price Target to $650

<p><strong>Ingredion</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) is set to give its latest quarterly earnings report on Friday, 2025-08-01. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Ingredion will report an <strong>earnings per share</strong> (EPS) of $2.78. </p>
<p>The announcement from Ingredion is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.56 in the last quarter, leading to a 1.99% drop in the share price on the following day.</p>
<p>Here's a look at Ingredion's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.41</td>
<td>2.56</td>
<td>2.58</td>
<td>2.51</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.97</td>
<td>2.63</td>
<td>3.05</td>
<td>2.87</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>-3.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753977749_0.png" alt="eps graph" /></p>
<h3>Ingredion Share Price Analysis</h3>
<p>Shares of Ingredion were trading at $132.11 as of July 30. Over the last 52-week period, shares are up 7.16%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on Ingredion</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Ingredion.</p>
<p>The consensus rating for Ingredion is Neutral, based on 1 analyst ratings. With an average one-year price target of $151.0, there's a potential 14.3% upside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Darling Ingredients and Bunge Global, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Darling Ingredients, with an average 1-year price target of $44.0, suggesting a potential 66.69% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Bunge Global, with an average 1-year price target of $85.0, suggesting a potential 35.66% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for Darling Ingredients and Bunge Global, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ingredion</td>
<td>Neutral</td>
<td>-3.67%</td>
<td>$466M</td>
<td>5.00%</td>
</tr>
<tr>
<td>Darling Ingredients</td>
<td>Buy</td>
<td>7.31%</td>
<td>$311.35M</td>
<td>0.29%</td>
</tr>
<tr>
<td>Bunge Global</td>
<td>Outperform</td>
<td>-13.22%</td>
<td>$597M</td>
<td>1.96%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Ingredion ranks in the middle for consensus rating. It is at the bottom for revenue growth. It is at the top for gross profit. It is at the bottom for return on equity.</p>
<h3>Unveiling the Story Behind Ingredion</h3>
<p>Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.</p>
<h3>Breaking Down Ingredion's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Revenue Challenges:</strong> Ingredion's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately <strong>-3.67%</strong>. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.</p>
<p><strong>Net Margin:</strong> Ingredion's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>10.87%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>5.0%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Ingredion's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>2.64%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.44</strong>, Ingredion adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/INGR/earnings"><strong>To track all earnings releases for Ingredion visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


INGR

Ingredion Earnings Preview

Politics

General

Reuters Cites Top Senate Democrat Schumer Calling Union Pacific Deal To Buy orfolk Southern "Hostile Takeover Of America's Infrastructure"

<p>Cinemark Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) will release its quarterly earnings report on Friday, 2025-08-01. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Cinemark Hldgs to report an <strong>earnings per share</strong> (EPS) of $0.76.</p>
<p>Investors in Cinemark Hldgs are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS missed by $0.07 in the last quarter, leading to a 0.0% drop in the share price on the following day.</p>
<p>Here's a look at Cinemark Hldgs's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.25</td>
<td>0.41</td>
<td>0.56</td>
<td>0.09</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.32</td>
<td>0.33</td>
<td>1.19</td>
<td>0.32</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-3.0%</td>
<td>0.0%</td>
<td>8.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753977737_0.png" alt="eps graph" /></p>
<h3>Cinemark Hldgs Share Price Analysis</h3>
<p>Shares of Cinemark Hldgs were trading at $27.25 as of July 30. Over the last 52-week period, shares are up 9.22%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Opinions on Cinemark Hldgs</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Cinemark Hldgs.</p>
<p>Cinemark Hldgs has received a total of 6 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $35.67, the consensus suggests a potential 30.9% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of  and Madison Square Garden, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Madison Square Garden, with an average 1-year price target of $41.0, suggesting a potential 50.46% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for  and Madison Square Garden, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cinemark Holdings</td>
<td>Buy</td>
<td>-6.65%</td>
<td>$355M</td>
<td>-8.16%</td>
</tr>
<tr>
<td>Madison Square Garden</td>
<td>Buy</td>
<td>6.20%</td>
<td>$103.59M</td>
<td>80.95%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Cinemark Holdings ranks lower in revenue growth compared to its peers. It also lags behind in gross profit margin. Additionally, its return on equity is lower than the peer average. Overall, Cinemark Holdings is positioned towards the bottom among its peers based on these key financial metrics.</p>
<h3>Discovering Cinemark Hldgs: A Closer Look</h3>
<p>Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.</p>
<h3>Understanding the Numbers: Cinemark Hldgs's Finances</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Cinemark Hldgs's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately <strong>-6.65%</strong> in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Communication Services sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Cinemark Hldgs's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-7.12%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Cinemark Hldgs's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-8.16%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Cinemark Hldgs's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-0.79%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> Cinemark Hldgs's debt-to-equity ratio is below the industry average at <strong>9.92</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/CNK/earnings"><strong>To track all earnings releases for Cinemark Hldgs visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Preview: Cinemark Hldgs's Earnings

<p>Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) will release its quarterly earnings report on Friday, 2025-08-01. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Brookfield Renewable to report an <strong>earnings per share</strong> (EPS) of $-0.30.</p>
<p>Anticipation surrounds Brookfield Renewable's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS beat by $0.05 in the last quarter, leading to a 0.0% drop in the share price on the following day.</p>
<p>Here's a look at Brookfield Renewable's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.40</td>
<td>-0.39</td>
<td>-0.26</td>
<td>-0.20</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.35</td>
<td>-0.06</td>
<td>-0.32</td>
<td>-0.28</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>6.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753977719_0.png" alt="eps graph" /></p>
<h3>Performance of Brookfield Renewable Shares</h3>
<p>Shares of Brookfield Renewable were trading at $27.05 as of July 30. Over the last 52-week period, shares are up 12.64%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/BEP/earnings"><strong>To track all earnings releases for Brookfield Renewable visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview: Brookfield Renewable

WIIM

Sun Communities shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 FFO guidance.

Commodities

Press Releases

Talos Energy Announces Successful Drilling Results at the Katmai West #2 Well in the U.S. Gulf of Mexico

Talos Energy Appoints Paul Goodfellow as President, Chief Executive Officer and Board Member

Talos Energy to Announce Fourth Quarter 2024 Results on February 26, 2025 and Host Earnings Conference Call on February 27, 2025

Talos Energy Announces Fourth Quarter and Full Year 2024 Operational and Financial Results

Talos Energy to Announce First Quarter 2025 Results on May 5, 2025 and Host Earnings Conference Call on May 6, 2025

Talos Energy Announces First Quarter 2025 Operational and Financial Results

Talos Announces Management Update

Talos Energy Announces Enhanced Corporate Strategy

NYSE Content Advisory: Pre-Market update + S&P 500 nears record

Talos Energy to Announce Second Quarter 2025 Results on August 6, 2025 and Host Earnings Conference Call on August 7, 2025

FRGE

SHLX

Black Stone Minerals, L.P. Common units representing limited partner interests

Black Stone Minerals

Civitas Resources

CNX Resources

California Resources Corporation Common Stock

California Resources

Crescent Energy Company Class A Common Stock

Crescent Energy

Dorchester Minerals, L.P. - Common Units Representing Limited Partnership Interests

Dorchester Minerals

VAALCO Energy

Gulfport Energy Corporation Common Shares

Gulfport Energy

Granite Ridge Resources, Inc. Common Stock

Granite Ridge Resources

HighPeak Energy

Kosmos Energy

Kimbell Royalty Partners Common Units Representing Limited Partner Interests

Kimbell Royalty Partners

Mach Natural Resources LP Common Units representing Limited Partner Interests

Mach Natural Resources

Murphy Oil

Northern Oil & Gas

Permian Basin Royalty Tr

Riley Exploration Permian, Inc. Common Stock

Riley Exploration Permian

Sabine Royalty

SM Energy

Sable Offshore

Sitio Royalties Corp. Class A Common Stock

Sitio Royalties

TXO Partners, L.P. Common Units Representing Limited Partner Interests

TXO Partners

Vital Energy, Inc. Common Stock, par value $0.01 per share

Comments

Talos Energy

Talos Energy (TALO) Opzioni

Talos Energy (NYSE:TALO) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO